Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Zyprexa – Schizophrenia treatment

Drug (Brand / Generic)

Zyprexa / olanzapine

Company / Licensee

Eli Lilly

Therapy Class

Atypical antipsychotic

Product Description

Possible receptor antagonist

Current Indication

Treatment of schizophrenia, psychotic disorders and bipolar disorders

Market Sector

CNS

Development Status

Approved in full in US January 2004, as part of Symbyax in March 2009, patent expires in 2011
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top